Cost-Effectiveness Analysis of Etanercept in Combination with Methotrexate for Rheumatoid Arthritis - Markov Model Based on Data from Serbia

Pubblicato online: 29 dic 2017

Pagine: 343 - 347

Ricevuto: 05 lug 2016

Accettato: 28 lug 2016

DOI: https://doi.org/10.1515/sjecr-2016-0070

Parole chiave

rheumatoid arthritis, biological therapy, etanercept, cost-effectiveness analysis

© 2017 Marina Kostic, published by De Gruyter Open

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.